- Relapsing forms of multiple sclerosis:
- Initially IM 7.5mcg weekly *1 week, then increased by 7.5mcg/week
- Maintenance: IM 30mcg weekly
Injection: 30mcg/0.5mL
Rotate IM injection sites between upper thighs and arms
Interferon; immunomodulator
It is thought to bind to type 1 interferon receptors and activates tyrosine kinase, producing antiviral, antiproliferative and immunomodulatory effects
- Headache
- Influenza-like symptoms
- Myalgia
- Asthenia
- Pain
- Nausea
- Fever
- Rigors
- Injection site reaction
- Depression
- UTI
- Dizziness
- Respiratory infection
- Arthralgia
- Infection
- Abdominal pain
- Chest pain
- Migraine headache
- Anemia
- Alopecia
- Vision changes
- Vasodilation
- Elevated ALT/AST
- Paresthesia
- Hypertonia
- Myasthenia
- Hypersensitivity to class/components
None restricted
Drug Status
Availability | Prescription only |
Pregnancy | Category C; weigh risk vs benefit |
Breastfeeding | Can be used |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Relibeta | 30mcg/0.5mL | Injection | 1’s | Galaxy Pharma | Galaxy Pharma |